Helldén A - Search Results

1

Pulmonary embolism associated with the use of anabolic steroids.

Liljeqvist S, Helldén A, Bergman U, Söderberg M. Liljeqvist S, et al. Among authors: hellden a. Eur J Intern Med. 2008 May;19(3):214-5. doi: 10.1016/j.ejim.2007.03.016. Epub 2007 Sep 19. Eur J Intern Med. 2008. PMID: 18395167

2

Search for the molecular basis of ultra-rapid CYP2C9-catalysed metabolism: relationship between SNP IVS8-109A>T and the losartan metabolism phenotype in Swedes.

Hatta FH, Teh LK, Helldén A, Hellgren KE, Roh HK, Salleh MZ, Aklillu E, Bertilsson L. Hatta FH, et al. Among authors: hellden a. Eur J Clin Pharmacol. 2012 Jul;68(7):1033-42. doi: 10.1007/s00228-012-1210-0. Epub 2012 Feb 1. Eur J Clin Pharmacol. 2012. PMID: 22294058

3

Fluconazole-induced intoxication with phenytoin in a patient with ultra-high activity of CYP2C9.

Helldén A, Bergman U, Engström Hellgren K, Masquelier M, Nilsson Remahl I, Odar-Cederlöf I, Ramsjö M, Bertilsson L. Helldén A, et al. Eur J Clin Pharmacol. 2010 Aug;66(8):791-5. doi: 10.1007/s00228-010-0820-7. Epub 2010 Apr 20. Eur J Clin Pharmacol. 2010. PMID: 20405111

4

The dopaminergic stabilizer pridopidine is to a major extent N-depropylated by CYP2D6 in humans.

Helldén A, Panagiotidis G, Johansson P, Waters N, Waters S, Tedroff J, Bertilsson L. Helldén A, et al. Eur J Clin Pharmacol. 2012 Sep;68(9):1281-6. doi: 10.1007/s00228-012-1248-z. Epub 2012 Mar 8. Eur J Clin Pharmacol. 2012. PMID: 22399238 Clinical Trial.

5

Lower CYP2C9 activity in Turkish patients with Behçet's disease compared to healthy subjects: a down-regulation due to inflammation?

Goktaş MT, Hatta F, Karaca O, Kalkisim S, Kilic L, Akdogan A, Babaoglu MO, Bozkurt A, Helldén A, Bertilsson L, Yasar U. Goktaş MT, et al. Among authors: hellden a. Eur J Clin Pharmacol. 2015 Oct;71(10):1223-8. doi: 10.1007/s00228-015-1899-7. Epub 2015 Aug 2. Eur J Clin Pharmacol. 2015. PMID: 26233334

6

Adverse drug reactions and impaired renal function in elderly patients admitted to the emergency department: a retrospective study.

Helldén A, Bergman U, von Euler M, Hentschke M, Odar-Cederlöf I, Ohlén G. Helldén A, et al. Drugs Aging. 2009;26(7):595-606. doi: 10.2165/11315790-000000000-00000. Drugs Aging. 2009. PMID: 19655826

7

Differential diagnosis of central nervous system involvement in a patient treated with acyclovir.

von Euler M, Axelsson G, Helldén A. von Euler M, et al. Among authors: hellden a. Ther Drug Monit. 2013 Aug;35(4):417-9. doi: 10.1097/FTD.0b013e31828faa35. Ther Drug Monit. 2013. PMID: 23851913

8

The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatment.

Helldén A, Lycke J, Vander T, Svensson JO, Odar-Cederlöf I, Ståhle L. Helldén A, et al. J Antimicrob Chemother. 2006 May;57(5):945-9. doi: 10.1093/jac/dkl067. Epub 2006 Mar 15. J Antimicrob Chemother. 2006. PMID: 16540518

9

Death delusion.

Helldén A, Odar-Cederlöf I, Larsson K, Fehrman-Ekholm I, Lindén T. Helldén A, et al. BMJ. 2007 Dec 22;335(7633):1305. doi: 10.1136/bmj.39408.393137.BE. BMJ. 2007. PMID: 18156240 Free PMC article.

10

The importance of correct estimation of renal function for drug treatment in hospitalized elderly patients, especially women: A prospective observational study .

Helldén A, Bergman U, Odar-Cederlöf I. Helldén A, et al. Clin Nephrol. 2019 Apr;91(4):254-264. doi: 10.5414/CN109536. Clin Nephrol. 2019. PMID: 30686288

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results